Annual Cash & Cash Equivalents
$140.60 M
-$43.84 M-23.77%
December 31, 2023
Summary
- As of February 8, 2025, MGX annual cash & cash equivalents is $140.60 million, with the most recent change of -$43.84 million (-23.77%) on December 31, 2023.
- During the last 3 years, MGX annual cash & cash equivalents has risen by +$101.31 million (+257.80%).
- MGX annual cash & cash equivalents is now -23.77% below its all-time high of $184.44 million, reached on December 31, 2022.
Performance
MGX Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$25.12 M
-$36.06 M-58.95%
September 1, 2024
Summary
- As of February 8, 2025, MGX quarterly cash and cash equivalents is $25.12 million, with the most recent change of -$36.06 million (-58.95%) on September 1, 2024.
- Over the past year, MGX quarterly cash and cash equivalents has dropped by -$36.06 million (-58.95%).
- MGX quarterly cash and cash equivalents is now -86.38% below its all-time high of $184.44 million, reached on December 1, 2022.
Performance
MGX Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
MGX Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -23.8% | -59.0% |
| 3 y3 years | +257.8% | -86.4% |
| 5 y5 years | +257.8% | -86.4% |
MGX Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -23.8% | +257.8% | -86.4% | at low |
| 5 y | 5-year | -23.8% | +257.8% | -86.4% | at low |
| alltime | all time | -23.8% | +257.8% | -86.4% | at low |
Metagenomi Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $25.12 M(-58.9%) |
| Jun 2024 | - | $61.18 M(-40.3%) |
| Mar 2024 | - | $102.56 M(-27.1%) |
| Dec 2023 | $140.60 M | $140.60 M(+38.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | $101.90 M(+97.3%) |
| Jun 2023 | - | $51.65 M(-72.0%) |
| Dec 2022 | $184.44 M(+369.4%) | - |
| Dec 2022 | - | $184.44 M |
| Dec 2021 | $39.30 M | - |
FAQ
- What is Metagenomi annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Metagenomi?
- What is Metagenomi annual cash & cash equivalents year-on-year change?
- What is Metagenomi quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Metagenomi?
- What is Metagenomi quarterly cash and cash equivalents year-on-year change?
What is Metagenomi annual cash & cash equivalents?
The current annual cash & cash equivalents of MGX is $140.60 M
What is the all time high annual cash & cash equivalents for Metagenomi?
Metagenomi all-time high annual cash & cash equivalents is $184.44 M
What is Metagenomi annual cash & cash equivalents year-on-year change?
Over the past year, MGX annual cash & cash equivalents has changed by -$43.84 M (-23.77%)
What is Metagenomi quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of MGX is $25.12 M
What is the all time high quarterly cash and cash equivalents for Metagenomi?
Metagenomi all-time high quarterly cash and cash equivalents is $184.44 M
What is Metagenomi quarterly cash and cash equivalents year-on-year change?
Over the past year, MGX quarterly cash and cash equivalents has changed by -$36.06 M (-58.95%)